Chemical Structure : PF-562271 besylate
CAS No.: 939791-38-5
Catalog No.: PC-42600Not For Human Use, Lab Use Only.
A potent, selective, ATP-competitive, reversible inhibitor of FAK and Pyk2 kinase with IC50 of 1.5 nM and 14 nM, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $98 | In stock | |
10 mg | $158 | In stock | |
25 mg | $258 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
PF-562271 besylate is a potent, selective, ATP-competitive, reversible inhibitor of FAK and Pyk2 kinase with IC50 of 1.5 nM and 14 nM, respectively.
PF-562271 displayes robust inhibition in an inducible cell-based assay measuring phospho-FAK with IC50 of 5 nM.
PF-562271 inhibits FAK phosphorylation in vivo in a dose-dependent fashion (EC50=93 ng/mL) after in tumor-bearing mice; orally bioavailable.
M.Wt | 665.6639 | |
Formula | C27H26F3N7O6S2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: 21.4 mg/mL |
|
Chemical Name/SMILES |
Methanesulfonamide, N-[3-[[[2-[(2,3-dihydro-2-oxo-1H-indol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]-N-methyl-, benzenesulfonate (1:1) |
1. Roberts WG, et al. Cancer Res. 2008 Mar 15;68(6):1935-44.
2. Stokes JB, et al. Mol Cancer Ther. 2011 Nov;10(11):2135-45.
3. Slack-Davis JK, et al. Mol Cancer Ther. 2009 Aug;8(8):2470-7.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright